CJC-1295
Growth Hormone Secretagogues research-only
Mechanism
No mechanism summary on file.
Identification
| CAS number | 446262-90-4 |
|---|---|
| Molecular formula | C165H269N47O46 |
Safety
Not FDA-approved. RFK Jr. (HHS Secretary) stated on JRE #2461 on February 27, 2026 that approximately 14 of 19 Category 2 peptides will be moved back to Category 1 (compoundable); CJC-1295 is expected to be included. As of late March 2026 no formal Federal Register action had been published. Research-market product is unregulated until that reclassification is executed.
Vendors selling CJC-1295
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Peptide Partners | — | — | — | 65 |
| Nuscience Peptides | — | — | — | 60 |
| Elite Research USA | — | — | — | 53 |
| Skye Peptides | — | — | — | 53 |
| Peptide Sciences | — | — | — | 26 |
Research
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, Bolia IK, Feingold CL, et al. · Am J Sports Med (2026) · review
source → Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev (2026) · review
source → Advances in the detection of growth hormone releasing hormone synthetic analogs.
Memdouh S, Gavrilović I, Ng K, et al. · Drug Test Anal (2021) ·
source → An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.
Timms M, Ganio K, Forbes G, et al. · Drug Test Anal (2019) ·
source → A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.
Timms M, Ganio K, Steel R · Drug Test Anal (2019) ·
source → Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.
Van Hout MC, Hearne E · Subst Use Misuse (2016) · review
source → Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.
Henninge J, Pepaj M, Hullstein I, et al. · Drug Test Anal (2010) ·
source → Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.
Alba M, Fintini D, Sagazio A, et al. · Am J Physiol Endocrinol Metab (2006) ·
source → Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Teichman SL, Neale A, Lawrence B, et al. · J Clin Endocrinol Metab (2006) · rct
source → Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
Ionescu M, Frohman LA · J Clin Endocrinol Metab (2006) · rct
source →